Ridloff Elena

Ridloff Elena is listed in filings as Director at Kymera Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 11, 2026, including sale activity. Recent filings connect the profile to Kymera Therapeutics, Inc. (KYMR), Sionna Therapeutics, Inc. (SION), and Kronos Bio, Inc. (KRON). The current snapshot covers public activity from Jun 26, 2024 to May 11, 2026. Reported amounts are shown as $261.0K to $289.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.